T. Rowe Price Associates
DDS icon

T. Rowe Price Associates’s Dillards DDS Stock Holding History

T. Rowe Price Associates’s Portfolio DDS Stock Details DDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67M Buy
2,913
+474
+19% +$296K ﹤0.01% 1913
2025
Q4 		$1.48M Buy
2,439
+97
+4% +$61.1K ﹤0.01% 1903
2025
Q3 		$1.44M Buy
2,342
+174
+8% +$89.9K ﹤0.01% 1889
2025
Q2 		$906K Buy
2,168
+17
+0.8% +$6.34K ﹤0.01% 2024
2025
Q1 		$771K Buy
2,151
+67
+3% +$28.8K ﹤0.01% 2073
2024
Q4 		$900K Buy
2,084
+166
+9% +$68.1K ﹤0.01% 2017
2024
Q3 		$736K Buy
1,918
+178
+10% +$67.9K ﹤0.01% 2093
2024
Q2 		$767K Sell
1,740
-127
-7% -$54.9K ﹤0.01% 2004
2024
Q1 		$881K Buy
1,867
+97
+5% +$39.8K ﹤0.01% 1967
2023
Q4 		$715K Sell
1,770
-9
-0.5% -$3.05K ﹤0.01% 2019
2023
Q3 		$589K Buy
1,779
+47
+3% +$15.5K ﹤0.01% 2028
2023
Q2 		$566K Sell
1,732
-34
-2% -$10.4K ﹤0.01% 2068
2023
Q1 		$544K Sell
1,766
-33
-2% -$11.7K ﹤0.01% 2071
2022
Q4 		$581K Sell
1,799
-157
-8% -$51.1K ﹤0.01% 2065
2022
Q3 		$534K Sell
1,956
-954
-33% -$252K ﹤0.01% 2086
2022
Q2 		$642K Buy
2,910
+422
+17% +$122K ﹤0.01% 2109
2022
Q1 		$668K Sell
2,488
-811
-25% -$209K ﹤0.01% 2212
2021
Q4 		$808K Buy
3,299
+198
+6% +$52.1K ﹤0.01% 2134
2021
Q3 		$535K Sell
3,101
-539
-15% -$103K ﹤0.01% 2357
2021
Q2 		$658K Buy
3,640
+158
+5% +$20.4K ﹤0.01% 2254
2021
Q1 		$336K Sell
3,482
-7,507
-68% -$610K ﹤0.01% 2524
2020
Q4 		$693K Sell
10,989
-655
-6% -$32K ﹤0.01% 2098
2020
Q3 		$425K Hold
11,644
– – ﹤0.01% 2157
2020
Q2 		$300K Sell
11,644
-162
-1% -$4.58K ﹤0.01% 2248
2020
Q1 		$436K Buy
11,806
+73
+0.6% +$4.27K ﹤0.01% 2049
2019
Q4 		$862K Buy
11,733
+383
+3% +$27.1K ﹤0.01% 1952
2019
Q3 		$750K Buy
11,350
+43
+0.4% +$2.75K ﹤0.01% 1938
2019
Q2 		$704K Buy
11,307
+20
+0.2% +$1.29K ﹤0.01% 1985
2019
Q1 		$813K Buy
11,287
+30
+0.3% +$2.06K ﹤0.01% 1923
2018
Q4 		$679K Sell
11,257
-1,182
-10% -$81.3K ﹤0.01% 1963
2018
Q3 		$950K Sell
12,439
-135
-1% -$11K ﹤0.01% 1901
2018
Q2 		$1.19M Buy
12,574
+14
+0.1% +$1.14K ﹤0.01% 1767
2018
Q1 		$1.01M Sell
12,560
-4,073
-24% -$294K ﹤0.01% 1793
2017
Q4 		$999K Buy
16,633
+4,883
+42% +$271K ﹤0.01% 1819
2017
Q3 		$659K Buy
11,750
+27
+0.2% +$1.66K ﹤0.01% 1978
2017
Q2 		$676K Hold
11,723
– – ﹤0.01% 1944
2017
Q1 		$612K Sell
11,723
-1
-0% -$55 ﹤0.01% 1980
2016
Q4 		$735K Buy
11,724
+4,520
+63% +$297K ﹤0.01% 1894
2016
Q3 		$454K Hold
7,204
– – ﹤0.01% 2053
2016
Q2 		$437K Buy
7,204
+1,375
+24% +$89.7K ﹤0.01% 2017
2016
Q1 		$495K Buy
5,829
+280
+5% +$21K ﹤0.01% 1976
2015
Q4 		$365K Buy
5,549
+49
+0.9% +$3.95K ﹤0.01% 2082
2015
Q3 		$481K Hold
5,500
– – ﹤0.01% 1963
2015
Q2 		$579K Hold
5,500
– – ﹤0.01% 1935
2015
Q1 		$751K Hold
5,500
– – ﹤0.01% 1825
2014
Q4 		$688K Hold
5,500
– – ﹤0.01% 1831
2014
Q3 		$599K Hold
5,500
– – ﹤0.01% 1866
2014
Q2 		$641K Hold
5,500
– – ﹤0.01% 1851
2014
Q1 		$508K Buy
5,500
+700
+15% +$63.3K ﹤0.01% 1912
2013
Q4 		$467K Sell
4,800
-3,200
-40% -$277K ﹤0.01% 1939
2013
Q3 		$626K Buy
8,000
+700
+10% +$56.7K ﹤0.01% 1812
2013
Q2 		$598K Buy
+7,300
New +$618K ﹤0.01% 1804

Other funds holding DDS

Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

T. Rowe Price Associates's DDS Position: Q1 2026 in Review

T. Rowe Price Associates increased its Dillards (DDS) stake by 19% in Q1 2026, buying an estimated $296K and bringing the position to 2,913 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1913.

T. Rowe Price Associates first reported a position in DDS in Q2 2013 and has held it in 52 quarters since. 316 funds tracked by Wall St. Rank hold DDS as of Q1 2026.

  • T. Rowe Price Associates held 2,913 shares of Dillards worth $1.67M as of Q1 2026.
  • T. Rowe Price Associates bought 474 Dillards shares in Q1 2026, an estimated $296K.
  • Dillards made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1913 holding.
  • T. Rowe Price Associates first reported a position in Dillards in Q2 2013 and has held it in 52 quarters since.
  • 316 funds tracked by Wall St. Rank held Dillards as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.